4-((4-(4-((1S,2S)-2-(4-FLUOROPHENYL)-1,2,3,4-TETRAHYDRO-6-HYDROXY-1-NAPHTHALENYL)-3-METHOXYPHENYL)-1-PIPERAZINYL)METHYL)-1-(4-((6S)-2,3,6,9-TETRAMETHYL-6H-THIENO(3,2-F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPIN-4-YL)PHENYL)-4-PIPERIDINOL
UNII UCR7C7H75G
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-((4-(4-((1s,2s)-2-(4-fluorophenyl)-1,2,3,4-tetrahydro-6-hydroxy-1-naphthalenyl)-3-methoxyphenyl)-1-piperazinyl)methyl)-1-(4-((6s)-2,3,6,9-tetramethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-4-yl)phenyl)-4-piperidinol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UCR7C7H75G.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3099600-10-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C51H56FN7O3S DPNGTIIBFLONNB-RJMGOWPUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-((4-(4-((1s,2s)-2-(4-fluorophenyl)-1,2,3,4-tetrahydro-6-hydroxy-1-naphthalenyl)-3-methoxyphenyl)-1-piperazinyl)methyl)-1-(4-((6s)-2,3,6,9-tetramethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-4-yl)phenyl)-4-piperidinol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.